PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026PhotoniX1 citationsOpen Access

AI-enhanced mid-infrared photothermal imaging reveals distinct spatial molecular signatures for label-free cancer staging

XYXin YePFPengcheng FuXTXiaobin Tang

Key Points

  • To evaluate the effectiveness of AI-enhanced mid-infrared photothermal imaging for cancer staging by identifying molecular signatures near tumor margins.
  • Developed AI-enhanced mid-infrared photothermal imaging (MIP) for spatial profiling of tissues.
  • Analyzed surgical specimens from patients with head and neck squamous cell carcinoma.
  • Conducted single-nucleus RNA sequencing to validate molecular profiles.
  • Employed machine learning to identify molecular signatures and improve staging predictions.
  • Identified spectroscopically defined transition zones (SDTZs) near tumor margins that exhibit metabolic changes.
  • Confirmed increased expression of SREBF1 and CPT1A in SDTZs through RNA sequencing.
  • Achieved a 3.7-fold increase in staging prediction accuracy over traditional methods using tumor core assessment.

Abstract

Abstract Precise tumor margin delineation remains critical for effective cancer treatment, yet traditional histopathological methods often miss early molecular changes indicative of malignancy. We developed artificial intelligence-enhanced mid-infrared photothermal imaging (AI-enhanced MIP), a label-free platform for automated spatial profiling of patient tissues at submicron resolution by acquiring intrinsic molecular spectroscopic information at each pixel. Analysis of surgical specimens from patients with head and neck squamous cell carcinoma at various pathological stages revealed spectroscopically defined transition zones (SDTZs) near tumor margins—regions that appear histologically normal but exhibit distinct metabolic alterations. Single-nucleus RNA sequencing validation confirmed elevated SREBF1 and CPT1A expression along with epithelial-mesenchymal transition signatures in SDTZs. Machine learning-assisted identification of SDTZ molecular signatures further improved staging prediction accuracy by 3.7-fold compared with using tumor core assessment alone. For clinical translation, AI-enhanced MIP requires no tissue pretreatment and enables rapid assessment using four selective wavenumbers, providing more precise tumor margin definition during intraoperative evaluation that could reduce recurrence while avoiding treatment delays.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ye et al. (2026) studied this question.

synapsesocial.com/papers/69aa70b8531e4c4a9ff5ac97https://doi.org/10.1186/s43074-026-00233-7
Ask AI
Helpful
Bookmark
Share
View Full Paper